Recent Trends of Lung Cancer in Korea
Jae Guk Lee, Ho Cheol Kim, Chang-Min Choi
Tuberc Respir Dis. 2021;84(2):89-95.   Published online 2021 Feb 10     DOI: https://doi.org/10.4046/trd.2020.0134
Citations to this article as recorded by Crossref logo
Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation–Positive Non–Small Cell Lung Cancer
Jang Ho Lee, Eun Young Kim, Cheol-Kyu Park, Shin Yup Lee, Min ki Lee, Seong-Hoon Yoon, Jeong Eun Lee, Sang Hoon Lee, Seung Joon Kim, Sung Yong Lee, Jun Hyeok Lim, Tae-Won Jang, Seung Hun Jang, Kye Young Lee, Seung Hyeun Lee, Sei Hoon Yang, Dong Won Park,
Cancer Research and Treatment.2023; 55(1): 112.     CrossRef
New Targeted Therapy for Non-Small Cell Lung Cancer
Eun Ki Chung, Seung Hyun Yong, Eun Hye Lee, Eun Young Kim, Yoon Soo Chang, Sang Hoon Lee
Tuberculosis and Respiratory Diseases.2023; 86(1): 1.     CrossRef
CDCP1 Expression Is a Potential Biomarker of Poor Prognosis in Resected Stage I Non-Small-Cell Lung Cancer
Yunha Nam, Chang-Min Choi, Young Soo Park, HyunA Jung, Hee Sang Hwang, Jae Cheol Lee, Jung Wook Lee, Jung Eun Lee, Jung Hee Kang, Byung Hun Jung, Wonjun Ji
Journal of Clinical Medicine.2022; 11(2): 341.     CrossRef
Impact of COPD Treatment on Survival in Patients with Advanced Non-Small Cell Lung Cancer
Hyunji Jo, Sojung Park, Nam Eun Kim, So Young Park, Yon Ju Ryu, Jung Hyun Chang, Jin Hwa Lee
Journal of Clinical Medicine.2022; 11(9): 2391.     CrossRef
Association between Low-Dose Computed Tomography Results and 1-Year Smoking Cessation in a Residential Smoking Cessation Program
Da-Som Shin, Hye-Mi Noh, Hong Ji Song, Kyung Hee Park, Young-Gyun Seo, Yu-Jin Paek
International Journal of Environmental Research and Public Health.2022; 19(9): 5510.     CrossRef
Rapid FEV1 Decline and Lung Cancer Incidence in South Korea
Hyun Woo Lee, Hyo-Jin Lee, Jung-Kyu Lee, Tae Yeon Park, Eun Young Heo, Deog Kyeom Kim
Chest.2022; 162(2): 466.     CrossRef
Two‐year efficacy of SNK01 plus pembrolizumab for non‐small cell lung cancer: Expanded observations from a phase I/IIa randomized controlled trial
Hyung Jun Park, Yong Man Kim, Jae Seob Jung, Wonjun Ji, Jae Cheol Lee, Chang‐Min Choi
Thoracic Cancer.2022; 13(14): 2050.     CrossRef
Prognostic significance of location index in resected T1-sized early-stage non-small cell lung cancer
Seung Wan Kang, Won Gi Jeong, Jong Eun Lee, In-Jae Oh, Sang Yun Song, Byung Chan Lee, Yun-Hyeon Kim
Acta Radiologica.2022; : 028418512211116.     CrossRef
A phase II , multicenter study of lazertinib as consolidation therapy in patients with locally advanced, unresectable, EGFR mutation‐positive non‐small cell lung canc
Juwhan Choi, Jeong Eun Lee, Chang‐Min Choi, In‐Jae Oh, Kye Young Lee, Tae Won Jang, Seung Hyeun Lee, Eun Young Kim, Dong Won Park, Sun Hyo Park, Sung Yong Lee
Thoracic Cancer.2022; 13(23): 3431.     CrossRef
Application of several machine learning algorithms for the prediction of afatinib treatment outcome in advanced‐stage EGFR ‐mutated non‐small‐cell lung cancer
Taeyun Kim, Sang Jin Lee, Tae‐Won Jang
Thoracic Cancer.2022; 13(23): 3353.     CrossRef
Patterns of Extrathoracic Metastasis in Lung Cancer Patients
Hyung Kyu Park, Joungho Han, Ghee Young Kwon, Min-Kyung Yeo, Go Eun Bae
Current Oncology.2022; 29(11): 8794.     CrossRef
Economic Burden of Recurrence in Completely Resected Stage IB-IIIA Non-Small Cell Lung Cancer: A Retrospective Study Using Nationwide Claims Data of South Korea
Joo-Young Byun, Ju-Eun Lee, Yoon-Bo Shim, Jihyun Kim, Sun Young Lee, Bo Ra Shin, Na Ri Yoon, Mi-Hai Park, Eui-Kyung Lee
Advances in Therapy.2022;[Epub]     CrossRef